A Rs 700-crore racket involving illegal sale and supply of codeine-based cough syrup (CBCS) was uncovered in Uttar Pradesh.
The Uttar Pradesh Food Safety and Drug Administration (FSDA) has proposed stricter rules for wholesale drug licensing to prevent misuse.
Over 3.25 crore bottles of cough syrup were supplied in UP during 2024-25, exceeding actual medical needs.
79 FIRs have been lodged against 161 firms and 85 people have been arrested in 36 districts.
Detailed Insights:
The FSDA has proposed geo-tagging of wholesale establishments, verification of storage capacity, and photographic documentation to enhance transparency.
The FSDA will propose to the Central Government the issuance of guidelines for the manufacture, supply, distribution, and monitoring of codeine-based cough syrups.
Investigations revealed a parallel distribution network using super stockists in Delhi and Ranchi, with unsubstantiated sales details to retail outlets.
A Special Investigation Team (SIT) was formed to conduct a detailed probe and submit a report to the Chief Minister next month.
District Magistrates have been instructed to initiate action under the Gangster Act to seize assets acquired through illegal narcotics.
The Allahabad High Court upheld proceedings under the NDPS Act and dismissed petitions filed by the accused.
Key Concepts Involved:
Codeine-Based Cough Syrup (CBCS): A cough syrup containing codeine, a narcotic substance, often misused for its intoxicating effects.
Narcotic Drugs and Psychotropic Substances (NDPS) Act: Indian legislation that prohibits the manufacture, possession, sale, purchase, transport, storage, and consumption of narcotic drugs and psychotropic substances.
Geo-tagging: The process of adding geographical identification metadata to various media such as photographs or videos.